Acotec Scientific Holdings Limited

HKEX:6669.HK

7.44 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

20232022202120202019
Revenue 473.848395.545303.813193.975124.91
Cost of Revenue 96.43359.19237.87430.19518.979
Gross Profit 377.415336.353265.939163.78105.931
Gross Profit Ratio 0.7960.850.8750.8440.848
Reseach & Development Expenses 190.07183.796141.28883.48725.479
General & Administrative Expenses 83.77787.84699.2220.0098.17
Selling & Marketing Expenses 97.54472.66158.80132.58136.266
SG&A 181.321160.507158.02152.5944.436
Other Expenses -18.985-7.885-6.70857.8169.887
Operating Expenses 352.406336.418292.601193.89379.802
Operating Income 25.00972.075-64.194-29.48625.969
Operating Income Ratio 0.0530.182-0.211-0.1520.208
Total Other Income Expenses Net -10.557-1.756-3.049-1.9613.379
Income Before Tax 14.45270.319-67.243-31.44726.708
Income Before Tax Ratio 0.030.178-0.221-0.1620.214
Income Tax Expense -0.0350.17711.83412.8453.603
Net Income 14.48770.142-79.077-44.29223.105
Net Income Ratio 0.0310.177-0.26-0.2280.185
EPS 0.0480.23-0.32-0.140.074
EPS Diluted 0.0480.23-0.32-0.140.074
EBITDA 70.54391.174-51.016-24.66429.867
EBITDA Ratio 0.1490.231-0.179-0.1240.239